---
$id: https://graph.org.ai/products/commodity/51111639
$type: Product
source: UNSPSC
code: "51111639"
title: "Fazarabine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fazarabine

**UNSPSC Code**: 51111639
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist with the molecular formula C8H12N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5V71D8JOKK, chemically known as 1,3,5-triazin-2 (1h)-one, 4-amino-1-.beta.-d-ribofuranosyl- but generally known as fazarabine, which bears US NIH Compound Identifier 1805. European Medicines Agency schedules Fazarabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07517MIG. The term FAZARABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). FAZARABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fazarabine under HS 29349990 and SITC 51579. As of Q4 2014, FAZARABINE remains the US FDA Preferred Term for this commodity. Fazarabine bears US NLM identifiers UMLS ID C0060103 and NCI Concept Code C1096. SMILES: O1C(C(O)C(O)C1N1C(=O)NC(NC1)N)CO.

